ANI Pharmaceuticals Inc

10-Year Study

ANIP.US · Healthcare · US · Common Stock

Executive Summary: ANI Pharmaceuticals Inc has compounded at 3.8% annually over the last 10 years, with a maximum drawdown of 69.9% and an annualized volatility of 46.9%.

1Y CAGR
+36.4%
3Y CAGR
+20.6%
5Y CAGR
+18.2%
10Y CAGR
+3.8%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
69.9%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.33
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
0.57
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
41.9%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2021 · +58.7%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2020 · -52.9%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
60%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
20263.7-9.74.11.5————————-1.1%
20256.15.58.25.8-17.111.1-2.947.6-2.0-1.1-6.3-7.042.8%
20241.221.22.2-4.5-1.7-1.93.2-3.0-6.4-4.0-0.0-3.40.3%
202311.2-6.5-5.1-5.019.719.3-2.422.5-9.86.3-19.310.737.1%
2022-12.3-7.3-24.95.02.5-1.915.47.7-12.920.18.7-4.1-12.7%
2021-1.72.024.2-7.93.22.0-3.2-10.68.213.910.112.058.7%
20200.5-22.6-15.1-1.8-22.44.1-8.45.9-10.0-9.616.0-1.8-52.9%
201919.422.47.20.6-1.918.02.9-22.611.37.2-21.10.137.0%
20184.2-4.6-9.11.96.65.50.2-13.1-2.9-14.214.5-19.0-30.1%
2017-0.3-2.3-16.29.3-19.37.14.1-1.59.410.622.4-9.46.3%
2016———35.119.13.18.6-1.411.1-10.0-1.32.980.1%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 46.9%. The dominant macroeconomic risk driver is SHV.US, accounting for 32.1% of variance. Idiosyncratic stock-specific factors contribute 36.1%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2016-03-0110000
2016-04-0113508.615567439098
2016-05-0116087.3440285205
2016-06-0116583.481877599526
2016-07-0118003.565062388592
2016-08-0117748.068924539515
2016-09-0119711.82412358883
2016-10-0117736.18538324421
2016-11-0117507.42721330957
2016-12-0118009.506833036245
2017-01-0117959.001782531195
2017-02-0117549.01960784314
2017-03-0114708.853238265003
2017-04-0116078.431372549021
2017-05-0112979.79797979798
2017-06-0113903.743315508022
2017-07-0114477.124183006536
2017-08-0114260.249554367203
2017-09-0115594.177064765303
2017-10-0117254.901960784315
2017-11-0121125.965537730248
2017-12-0119147.355912061797
2018-01-0119952.465834818777
2018-02-0119034.462269756386
2018-03-0117296.494355317885
2018-04-0117632.20439691028
2018-05-0118802.733214497923
2018-06-0119845.513963161022
2018-07-0119890.077243018422
2018-08-0117290.552584670233
2018-09-0116797.385620915036
2018-10-0114417.706476530007
2018-11-0116515.15151515152
2018-12-0113374.925727866907
2019-01-0115965.537730243615
2019-02-0119545.45454545455
2019-03-0120956.625074272135
2019-04-0121087.3440285205
2019-05-0120695.187165775405
2019-06-0124420.677361853835
2019-07-0125130.71895424837
2019-08-0119459.29887106358
2019-09-0121651.812240047533
2019-10-0123205.585264408794
2019-11-0118306.595365418896
2019-12-0118321.44979203803
2020-01-0118419.489007724304
2020-02-0114263.22043969103
2020-03-0112103.386809269163
2020-04-0111886.512180629828
2020-05-019227.569815805111
2020-06-019607.843137254904
2020-07-018796.791443850268
2020-08-019316.696375519907
2020-09-018380.867498514559
2020-10-017572.78669043375
2020-11-018781.937017231136
2020-12-018627.450980392157
2021-01-018478.906714200832
2021-02-018645.276292335117
2021-03-0110736.779560308973
2021-04-019887.106357694594
2021-05-0110204.991087344031
2021-06-0110412.953060011885
2021-07-0110080.213903743315
2021-08-019010.695187165777
2021-09-019750.445632798575
2021-10-0111105.16934046346
2021-11-0112222.222222222223
2021-12-0113689.839572192515
2022-01-0112008.318478906716
2022-02-0111125.965537730244
2022-03-018351.158645276293
2022-04-018767.082590612004
2022-05-018986.928104575165
2022-06-018814.616755793228
2022-07-0110175.282234105765
2022-08-0110959.59595959596
2022-09-019548.425430778374
2022-10-0111464.646464646466
2022-11-0112462.86393345217
2022-12-0111951.871657754013
2023-01-0113288.770053475935
2023-02-0112430.18419489008
2023-03-0111800.35650623886
2023-04-0111206.179441473561
2023-05-0113410.576351752823
2023-06-0115992.275698158051
2023-07-0115612.00237670826
2023-08-0119129.530600118836
2023-09-0117248.960190136662
2023-10-0118342.245989304814
2023-11-0114797.9797979798
2023-12-0116381.461675579325
2024-01-0116583.481877599526
2024-02-0120103.98098633393
2024-03-0120537.730243612597
2024-04-0119607.843137254902
2024-05-0119281.04575163399
2024-06-0118918.597742127156
2024-07-0119524.65834818776
2024-08-0118939.39393939394
2024-09-0117724.3018419489
2024-10-0117006.833036244803
2024-11-0117002.37670825906
2024-12-0116423.054070112896
2025-01-0117421.271538918598
2025-02-0118386.80926916221
2025-03-0119890.077243018422
2025-04-0121039.809863339273
2025-05-0117445.03862150921
2025-06-0119385.026737967917
2025-07-0118820.558526440884
2025-08-0127777.77777777778
2025-09-0127213.309566250744
2025-10-0126916.221033868096
2025-11-0125207.961972667854
2025-12-0123452.168746286396
2026-01-0124316.696375519907
2026-02-0121954.84254307784
2026-03-0122846.108140225788
2026-04-0123193.70172311349
Annual Return Matrix
YearAnnual Return
20170.06318046849224679
2018-0.3014740108611327
20190.3698356286095068
2020-0.5291065347819037
20210.5867768595041323
2022-0.126953125
20230.37061894108873994
20240.0025389916575988547
20250.4280028943560057
2026-0.011021028629338847
Total Factor Risk
0.46946319935395714
VTI.US Exposure
0.03434410441527199
VEA.US Exposure
0.008389228122641998
VWO.US Exposure
-0.00015994777600903778
QQQ.US Exposure
-0.005682716887009444
VTV.US Exposure
-0.028111621432306735
IJR.US Exposure
0.08783518386356545
QUAL.US Exposure
0.03564688218463114
SHV.US Exposure
0.3210589595816966
TLT.US Exposure
0.0179026698625071
LQD.US Exposure
0.006830639481156285
HYG.US Exposure
0.026746422297371206
GLD.US Exposure
-0.00006551725255773093
USO.US Exposure
0.002757687335867641
VNQ.US Exposure
0.02133725626344423
BTC-USD.CC Exposure
-0.00024689401905570086
CPER.US Exposure
-0.0023057363577922534
VIX.INDX Exposure
0.010499358702178777
UUP.US Exposure
0.0022948487051313022
TIP.US Exposure
0.09955836269766541
Idiosyncratic Exposure
0.3613708302116017
Value Score
40.7
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
46.9%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →23.3x
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$1.7B
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+2.2%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-4.7%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
21.0% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
0.43
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is ANI Pharmaceuticals Inc a high-risk investment?

ANI Pharmaceuticals Inc (ANIP.US) has an annualized volatility of 46.9% and experienced a maximum drawdown of 69.9% over the last 10 years. Its primary macro risk driver is SHV.US.

What is the 10-year return of ANIP.US?

Over the past 10 years, ANIP.US has generated a Compound Annual Growth Rate (CAGR) of 3.8%. It has had a positive return in 60% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on ANI Pharmaceuticals Inc

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest